A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease

NCT07211776 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Thyroid Eye Disease (TED)

Interventions

DRUG: ZL-1109 (VRDN-003)
DRUG: Placebo

Sponsor

Zai Lab (Shanghai) Co., Ltd.